BLOOD GROUP TYPING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

The global blood group typing market is estimated to be valued at USD 2,185.7 Mn in 2026 and is expected to reach USD 3,612.8 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 7.4% from 2026 to 2033. The global blood group typing market is the major part of the clinical diagnostics market and consists of products and technologies used in blood group identification, compatibility testing for blood and organ transplants and prenatal testing. The blood group typing market is based on ABO and Rh blood grouping typing techniques with extended additional blood group testing for transfusion transmitted infections. The system and reagents are used for blood grouping testing in hospitals, laboratories, diagnostics and blood banks.

The growing need for safe blood transfusions along with increasing number of surgical procedures and rising prevalence of chronic diseases that require constant blood support are contributing towards the market growth. In addition, technological upgradations like automated immunohematology analyzers, molecular blood typing, and high throughput testing platforms are improving the accuracy of testing processes and operational efficiencies. Moreover, growing blood donation drives, improved healthcare infrastructure and strict regulatory mandates on blood safety standards are further expanding the deployment of blood group typing solutions across the globe.

Market Dynamics

The global blood group typing market is driven by the increasing need for safe blood transfusions, increasing number of surgeries being performed and growing incidence of chronic diseases including cancer, kidney diseases and blood related illnesses that are indication for multiple blood transfusions. Growing importance of blood safety and aging population are also supplementing the market growth. Other factors that are expected to drive this market include specifications of advanced automated immunohematology analyzers, molecular typing approaches, and point-of-care testing solutions.

However, a number of constraints are present in the market, such as high-priced modern blood typing techniques, regulatory hurdles and requirement of trained person to operate sophisticated diagnostic machines. Nevertheless, emerging opportunities are seen from rising healthcare infrastructure in emerging economies, rising investments in blood banks and rising use of automation in laboratories. Improved workflow Automation with the integration of artificial intelligence and digital diagnostics in transfusion medicine is also seen to bring opportunities.

Key Features of the Study

• This report provides in-depth analysis of the global blood group typing market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global blood group typing market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Bio-Rad Laboratories, Inc., Grifols, S.A., QuidelOrtho Corporation, Immucor, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Merck KGaA, BAG Diagnostics GmbH, Diagast SAS, and Novacyt Group
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global blood group typing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood group typing market

Market Segmentation (Version-2026)

• Product Insights (Revenue, USD Mn, 2021 - 2033)
  • Reagents and Consumables
  • Instruments
  • Software and Services
• Technique Insights (Revenue, USD Mn, 2021 - 2033)
  • Serological Testing
  • Molecular Testing
• End User Insights (Revenue, USD Mn, 2021 - 2033)
  • Hospitals
  • Blood Banks
  • Diagnostic Laboratories
  • Others
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Bio-Rad Laboratories, Inc.
  • Grifols, S.A.
  • QuidelOrtho Corporation
  • Immucor, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Merck KGaA
  • BAG Diagnostics GmbH
  • Diagast SAS
  • Novacyt Group